Literature DB >> 30651269

CYP24A1 mutations and hypervitaminosis D.

Jamie Willows1, John A Sayer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30651269      PMCID： PMC6399622          DOI： 10.7861/clinmedicine.19-1-92a

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  4 in total

1.  Risks of the 'Sunshine pill' - a case of hypervitaminosis D.

Authors:  Sebastien Ellis; Georgios Tsiopanis; Tanuj Lad
Journal:  Clin Med (Lond)       Date:  2018-08       Impact factor: 2.659

2.  Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.

Authors:  Giacomo Colussi; Liat Ganon; Silvana Penco; Maria Elisabetta De Ferrari; Federica Ravera; Marialuisa Querques; Paola Primignani; Eli J Holtzman; Dganit Dinour
Journal:  Nephrol Dial Transplant       Date:  2013-11-13       Impact factor: 5.992

Review 3.  Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.

Authors:  Tilman Jobst-Schwan; Andrea Pannes; Karl Peter Schlingmann; Kai-Uwe Eckardt; Bodo B Beck; Michael S Wiesener
Journal:  Kidney Blood Press Res       Date:  2015-08-22       Impact factor: 2.687

4.  Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole.

Authors:  Judith Sayers; Ann Marie Hynes; Shalabh Srivastava; Frances Dowen; Richard Quinton; Harish K Datta; John A Sayer
Journal:  Clin Kidney J       Date:  2015-05-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.